Devil's claw

EMA lists devil's claw root as well-established use for articular and low back pain, but WHO advises against routine use in chronic primary low back pain.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
Standardised extract delivering 50–100 mg/day harpagoside, typically 600 mg extract three times daily
Time to effect
Not established here
Safety
Has documented cautions

Evidence ratings summarise published research on Devil's claw in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Devil's claw

Interactions

Taking any medication?

Check Devil's claw against it.

Why

Devil's claw (Harpagophytum procumbens) root holds an EMA Well-Established Use monograph for short-term use in articular and low back pain, which is a regulatory status rather than a trial result. The 2023 WHO guideline on chronic primary low back pain in adults advises against routine use of devil's claw.

How it works

Iridoid glycosides (harpagoside, harpagide, procumbide) inhibit COX-2 expression and TNF-α release. Bitter principles also stimulate gastric and biliary secretion: the historical European use as a digestive bitter.

Expected onset · Not established here; the EMA monograph covers short-term use

How to take

Dosage

Standardised extract delivering 50–100 mg/day harpagoside, typically 600 mg extract three times daily.

Timing

With meals to reduce GI upset

On the label

Look for a Harpagophytum procumbens or H. zeyheri root extract with stated harpagoside content of at least 1.5%.

Studied in

Adults with articular or low back pain asking about the EMA-listed short-term use; WHO does not recommend it for chronic primary low back pain.

Safety

Avoid in active peptic ulcer disease (stimulates gastric acid secretion). Caution with warfarin (modest antiplatelet effect) and with antiarrhythmics. Avoid in pregnancy (uterine stimulation reported in animal work). May affect blood glucose; monitor in diabetes.
Loading interactions…

Evidence

At a glance

The EMA lists devil's claw root as a well-established-use herbal medicine for articular pain and low back pain, a regulatory status rather than a trial result. The 2023 WHO guideline on non-surgical management of chronic primary low back pain in adults, however, advises against routine use of devil's claw. The two sources point in different directions.

GRADE certainty: Low — rated by Healicus using the GRADE method; no trial abstract was available, and the WHO guideline advises against use for chronic primary low back pain while the EMA lists it as well-established use

Questions people ask

Does Devil's claw work?

The EMA lists devil's claw root as a well-established-use herbal medicine for articular pain and low back pain, a regulatory status rather than a trial result. The 2023 WHO guideline on non-surgical management of chronic primary low back pain in adults, however, advises against routine use of devil's claw. The two sources point in different directions. Certainty of the evidence: Low, rated by Healicus using the GRADE method; no trial abstract was available, and the WHO guideline advises against use for chronic primary low back pain while the EMA lists it as well-established use.

How is Devil's claw taken?

Standardised extract delivering 50–100 mg/day harpagoside, typically 600 mg extract three times daily. Timing: With meals to reduce GI upset. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Avoid in active peptic ulcer disease (stimulates gastric acid secretion). Caution with warfarin (modest antiplatelet effect) and with antiarrhythmics. Avoid in pregnancy (uterine stimulation reported in animal work). May affect blood glucose; monitor in diabetes. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Gagnier et al., Cochrane Database Syst Rev 2016, herbal medicine for low-back pain; EMA HMPC monograph, Harpagophytum procumbens DC. and/or H. zeyheri Decne., radix (Well-Established Use); WHO guideline (2023): WHO Guideline for Non-Surgical Management of Chronic Primary Low Back Pain in Adults.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.